Cargando…

Effect of systemic corticosteroid therapy for acute heart failure patients with elevated C‐reactive protein

AIMS: The current study explores whether degree of inflammation, reflected by C‐reactive protein (CRP) level, modifies the effect of intravenous (IV) corticosteroid administered in the emergency department (ED) on clinical outcomes in patients with acute heart failure (AHF). METHODS AND RESULTS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miró, Òscar, Takagi, Koji, Davison, Beth A., Edwards, Christopher, Freund, Yonathan, Jacob, Javier, Llorens, Pere, Mebazaa, Alexandre, Cotter, Gad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288737/ https://www.ncbi.nlm.nih.gov/pubmed/35393762 http://dx.doi.org/10.1002/ehf2.13926

Ejemplares similares

Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research
por: Cotter, Gad, et al.
Publicado: (2021)

Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial
por: Takagi, Koji, et al.
Publicado: (2021)

Global differences in acute heart failure treatment: analysis of the STRONG‐HF site feasibility questionnaire
por: Novosadova, Maria, et al.
Publicado: (2023)

Plasma and Urinary Biomarkers Improve Prediction of Mortality through 1 Year in Intensive Care Patients: An Analysis from FROG-ICU
por: Davison, Beth A., et al.
Publicado: (2023)

Systemic Inflammation Evaluated by Interleukin-6 or C-Reactive Protein in Critically Ill Patients: Results From the FROG-ICU Study
por: Picod, Adrien, et al.
Publicado: (2022)

Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study (SEISMiC)
por: Metra, Marco, et al.
Publicado: (2022)

Association between Covid-19 and Pulmonary Embolism (AC-19-PE study)
por: Miró, Òscar, et al.
Publicado: (2020)

Management of Acute Heart Failure during an Early Phase
por: Takagi, Koji, et al.
Publicado: (2020)

Early and comprehensive care bundle in the elderly for acute heart failure in the emergency department: study protocol of the ELISABETH stepped-wedge cluster randomized trial
por: Freund, Yonathan, et al.
Publicado: (2019)

Pulmonary embolism severity and in-hospital mortality: An international comparative study between COVID-19 and non-COVID patients
por: Miró, Òscar, et al.
Publicado: (2022)

The Mobile App Development and Assessment Guide (MAG): Delphi-Based Validity Study
por: Llorens-Vernet, Pere, et al.
Publicado: (2020)

Standards for Mobile Health–Related Apps: Systematic Review and Development of a Guide
por: Llorens-Vernet, Pere, et al.
Publicado: (2020)

Assessing the Quality of Mobile Health-Related Apps: Interrater Reliability Study of Two Guides
por: Miró, Jordi, et al.
Publicado: (2021)

Clinical characteristics and outcomes of black African heart failure patients with preserved, mid‐range, and reduced ejection fraction: a post hoc analysis of the THESUS‐HF registry
por: Dzudie, Anastase, et al.
Publicado: (2020)

N‐terminal pro BNP and galectin‐3 are prognostic biomarkers of acute heart failure in sub‐Saharan Africa: lessons from the BAHEF trial
por: Sani, Mahmoud U., et al.
Publicado: (2020)

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
por: Metra, Marco, et al.
Publicado: (2010)

Pre‐hospital management protocols and perceived difficulty in diagnosing acute heart failure
por: Harjola, Pia, et al.
Publicado: (2019)

Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis
por: Davison, Beth A, et al.
Publicado: (2021)

Vasodilators in the treatment of acute heart failure: what we know, what we don’t
por: Metra, Marco, et al.
Publicado: (2008)

Heart Failure and Importance of Collaboration of Professional Organizations: The Role of the Heart Failure Association of the European Society of Cardiology and Its Committee on National Heart Failure Societies
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2015)

Acute Heart Failure Management
por: Čerlinskaitė, Kamilė, et al.
Publicado: (2018)

Frequency of five unusual presentations in patients with COVID-19: results of the UMC-19-S(1)
por: Miró, Òscar, et al.
Publicado: (2020)

Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S(2)
por: Miró, Òscar, et al.
Publicado: (2021)

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
por: Metra, Marco, et al.
Publicado: (2013)

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design
por: Bartunek, Jozef, et al.
Publicado: (2015)

Echocardiographic predictors of outcome in acute heart failure patients in sub-Saharan Africa: insights from THESUS-HF
por: Sani, Mahmoud U, et al.
Publicado: (2017)

Influence of corticosteroid therapy on viral reactivation in drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms
por: Tohyama, Mikiko, et al.
Publicado: (2020)

Elevated plasma endothelin‐1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure
por: Zymliński, Robert, et al.
Publicado: (2020)

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2014)

Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome—an analysis from RELAX-AHF
por: Voors, Adriaan A, et al.
Publicado: (2014)

Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial
por: Biegus, Jan, et al.
Publicado: (2019)

Prevalence, clinical characteristics and outcomes ofvalvular atrial fibrillation in a cohort of African patientswith acute heart failure: insights from the THESUS-HFregistry
por: Mahmoud, U Sani, et al.
Publicado: (2018)

Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study
por: Meyer, Sven, et al.
Publicado: (2016)

Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
por: van Essen, Bart J., et al.
Publicado: (2022)

Emergency department direct discharge compared to short-stay unit admission for selected patients with acute heart failure: analysis of short-term outcomes
por: Sánchez-Marcos, Carolina, et al.
Publicado: (2023)

Influence of corticosteroids on C-reactive protein in patients with rheumatoid arthritis
por: Mysler, E, et al.
Publicado: (2004)

Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2017)

Relaxin: Review of Biology and Potential Role in Treating Heart Failure
por: Teichman, Sam L., et al.
Publicado: (2010)

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study
por: Teerlink, John R., et al.
Publicado: (2017)

Elevated third trimester corticosteroid levels are associated with fewer offspring infections
por: Prince, Nicole, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v9rl5h7c5p932ri4qrgkubq1ci